z-logo
Premium
Genotype analysis in H ungarian patients with multiple primary melanoma
Author(s) -
Hatvani Zsófia,
Brodszky Valentin,
Mazán Mercédesz,
Pintér Dóra,
Hársing Judit,
Tóth Veronika,
Somlai Beáta,
Kárpáti Sarolta
Publication year - 2014
Publication title -
experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.108
H-Index - 96
eISSN - 1600-0625
pISSN - 0906-6705
DOI - 10.1111/exd.12382
Subject(s) - cdkn2a , melanoma , microphthalmia associated transcription factor , medicine , genotype , genetic predisposition , oncology , disease , cancer research , cancer , biology , gene , genetics , transcription factor
Multiple primary melanoma patients ( MPM ps) have better prognosis and are more prone to genetic predisposition than single melanoma patients. We aimed to compare genetic background ( CDKN 2A, CDK 4, MITF , MC 1R ) of 43 Hungarian MPM ps with their clinicopathological data. We observed a higher rate of synchronous first and second melanoma ( MM ) (49%) and a higher frequency of non‐melanoma tumor co‐occurrence (42%) than reported previously. CDKN 2A mutation frequency was 4.7% (E69G, R99P). We identified a new human MC 1R variant (D117G) and reported MC 1R variant distributions in Hungarian MM s for the first time. The rare R163Q was exceptionally common among Hungarian MPM ps, a variant otherwise frequent in Asia, but not in Europe. MC 1R ‘R’ carriers showed histopathological signs of a more progressive disease than ‘r’ carriers did; however, tumor‐infiltrating lymphocytes ( TIL s) in their second melanomas occurred significantly more frequently. Calculating 5‐year overall survival, ‘R’ carriers showed more unfavourable prognosis (87%) than ‘r’ carriers did (95%).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom